Correlation of Gene Status and Clinical Outcomes in ESCC

Retrospective Study of Gene Status and Clinical Outcome of Esophageal Squamous Cell Carcinoma(ESCC).

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03831828

Acronym

ESCC

Enrollment

Registered

2019-02-06

Start date

2018-12-26

Completion date

2019-04-01

Last updated

2019-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prognosis of Patients With ESCC

Brief summary

The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information.

Exclusion criteria

* Patients who also suffering from other tumors.

Design outcomes

Primary

Measure	Time frame	Description
Gene test	2019-2 to 2019-4	466 Tumor-associated gene test by next-generation sequencing(NGS)

Countries

China

Contacts

Primary ContactJunfeng Liu, MD

13931152296@163.com13931152296

Outcome results